Abstract:Objective: We aimed to use molecular biomarkers and clinical data and echocardiograms that were collected during admission to predict bronchopulmonary dysplasia (BPD) in preterm infants with gestational age ≤32 weeks. Methods: Eighty-two patients (40 with BPD, BPD group and 42 healthy as controls, non-BPD group) admitted to the Department of Neonatology of the Children's Hospital of Soochow University between October 1, 2018, and February 29, 2020, were enrolled in this study at the tertiary hospital. Basic clinical data on the perinatal period, echocardiographic measurements, and molecular biomarkers (N-terminal-pro-B-brain natriuretic peptide, NT-proBNP) were collected. We used multiple logistic regression analysis to establish an early predictive model for detecting BPD development in preterm infants of gestational age ≤32 weeks. We also used a receiver operating characteristic curve to assess the sensitivity and speciﬁcity of the model. Results: No significant differences were found between the BPD and non-BPD groups in terms of sex, birth weight, gestational age, incidence of asphyxia, maternal age, gravidity, parity, mode of delivery, premature rupture of membranes >18 h, use of prenatal hormones, placental abruption, gestational diabetes mellitus, amniotic fluid contamination, prenatal infections, and maternal diseases. The use of caffeine, albumin, gamma globulin; ventilation; days of FiO2 ≥ 40%; oxygen inhalation time; red blood cell suspension infusion volume (ml/kg); and proportion of infants who received total enteral nutrition (120 kcal/kg.d) ≥24 d after birth were higher in the BPD group than in the non-BPD group. The levels of hemoglobin, hematocrit, and albumin in the BPD group were significantly lower than those in the non-BPD group. The total calorie intake was significantly lower in the BPD group on the 3rd, 7th, and 14th day after birth than in the non-BPD group (P < 0.05). The incidence rates of patent ductus arteriosus (PDA), pulmonary hypertension, and tricuspid regurgitation were significantly higher in the BPD group than in the non-BPD group (P < 0.05). The serum level of NT-proBNP 24 h after birth was significantly higher in the BPD group than in the non-BPD group (P < 0.05). Serum NT-proBNP levels were significantly higher in infants with severe BPD than in those with mild or moderate BPD (P < 0.05). Conclusion: As there were various risk factors for BPD, a combining clinical data, molecular biomarkers, and echocardiogram measurements can be valuable in predicting the BPD. The tricuspid regurgitation flow rate (m/s), NT-proBNP (pg/ml), ventilator-associated pneumonia, days of FiO2 ≥ 40% (d), red blood cell suspension infusion volume (ml/kg), and proportion of infants who received total enteral nutrition (120 kcal/kg.d) ≥24 d after birth were the most practical factors considered for designing an appropriate model for predicting the risk of BPD.

Late Breaking Abstract - Detection of bronchopulmonary dysplasia (BPD) in preterm infants with an artificial neural network (ANN) trained using air flow time series (TS) measured during tidal breathing (Tb)

A Prediction Model of Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.

Epidemiology of Respiratory Distress and the Illness Severity in Late Preterm or Term Infants: A Prospective Multi-Center Study

Altered relaxation times in MRI indicate bronchopulmonary dysplasia.

Early Diagnosis of Bronchopulmonary Dysplasia with E-Nose: A Pilot Study in Preterm Infants

Risk Identification of Bronchopulmonary Dysplasia in Premature Infants Based on Machine Learning

LSC Abstract – Early biomarkers indicating the development of neonatal chronic lung disease defined by clinical and imaging parameters

Combining artificial intelligence and conventional statistics to predict bronchopulmonary dysplasia in very preterm infants using routinely collected clinical variables

Early Severity Prediction of BPD for Premature Infants from Chest X-ray Images Using Deep Learning: A Study at the 28th Day of Oxygen Inhalation

Automated MRI Lung Segmentation and 3D Morphologic Features for Quantification of Neonatal Lung Disease

N-terminal-probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study

Predictive values of clinical data,molecular biomarkers, and echocardiographic measurements in preterm infants with bronchopulmonary dysplasia

An Early Prediction Model for Estimating Bronchopulmonary Dysplasia in Preterm Infants

A Neural Network-based Approach to Prediction of Preterm Birth using Non-invasive Tests

Machine learning for prediction of bronchopulmonary dysplasia-free survival among very preterm infants

Prediction of Neonatal Respiratory Distress in Term Babies at Birth from Digital Stethoscope Recorded Chest Sounds

Detecting central apneas using multichannel signals in premature infants

Risk Factors and Machine Learning Prediction Models for Bronchopulmonary Dysplasia Severity in the Chinese Population

Using machine-learning models to predict extubation failure in neonates with bronchopulmonary dysplasia

Risk prediction of bronchopulmonary dysplasia in preterm infants by the nomogram model

Cardiorespiratory Monitoring Data to Predict Respiratory Outcomes in Extremely Preterm Infants